Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$13.30M
Gross Margin
-486.44%
TTM Avg
-208.47%
3Y Avg
-109.22%
5Y Avg
-72.81%
Market Cap
$13.20M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.86M
Gross Margin
-19.74%
TTM Avg
7.58%
3Y Avg
35.31%
5Y Avg
31.20%
Market Cap
$12.78M
Gross Margin
18.76%
TTM Avg
9.38%
3Y Avg
50.69%
5Y Avg
33.79%
Market Cap
$14.05M
Gross Margin
84.15%
TTM Avg
52.79%
3Y Avg
35.70%
5Y Avg
25.98%
Market Cap
$12.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IN8bio, Inc. (INAB) | $13.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -486.44% | -208.47% | -109.22% | -72.81% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -19.74% | 7.58% | 35.31% | 31.20% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | 18.76% | 9.38% | 50.69% | 33.79% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | 84.15% | 52.79% | 35.70% | 25.98% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -137.55% | -73123.88% | -36779.95% | -24519.97% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
